SupplySide Global 2025: Rousselot’s collagen peptides pioneer new approach to metabolic wellness
05 Nov 2025 | Rousselot
Rousselot highlighted its Nextida GC, a specific collagen peptide composition shown to naturally stimulate GLP-1 and GIP secretion, supporting the modulation of insulin response and reducing post-meal blood glucose spikes. Florencia Moreno Torres, global marketing manager, tells us how the company’s Nextida platform is expected to transform approaches to metabolic wellness, both now and in the future.
















